Search research articles
Contact Us
Filters
Showing results (21-30 of 74) with videos related to
Page
of 8
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 15, 2009
Risk of hepatitis B virus reactivation in patients who are hepatitis B surface antigen negative/antibody to hepatitis B core antigen positive and the role of routine antiviral prophylaxis
Yu Xuan Koo, Daniel S W Tan, Bee Huat Tan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 15, 2012
To SMILE or not: supportive care matters
Alexandre Chan, Tiffany Tang, Terence Ng, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
June 19, 2012
Clinical pharmacy services and research for lymphoma patients at a cancer center
Alexandre Chan, Vivianne Shih, Joen Chiang, et al.
Annals of Hematology
|
August 3, 2010
Prognostic impact of bleomycin-induced pneumonitis on the outcome of Hodgkin's lymphoma
Joanne Ngeow, Iain B Tan, Ravindran Kanesvaran, et al.
Acta Oncologica (Stockholm, Sweden)
|
October 6, 2007
Capecitabine and oxaliplatin (XELOX) is safe and effective in patients with advanced gastric cancer
Richard Quek, Wan Teck Lim, Kian Fong Foo, et al.
Acta Oncologica (Stockholm, Sweden)
|
October 21, 2009
Second hematologic malignancies after ABVD: Two case reports and a retrospective study of 183 Hodgkin lymphoma patients
Carrie Leong, Joanne Ngeow, Iain Tan, et al.
World Journal of Gastroenterology
|
August 13, 2009
"Anti-HBc alone" in human immunodeficiency virus-positive and immuno-suppressed lymphoma patients
Yu Xuan Koo, Daniel S W Tan, Iain B H Tan, et al.
Asia-Pacific Journal of Clinical Oncology
|
February 22, 2011
Comparison of daily filgrastim and pegfilgrastim to prevent febrile neutropenia in Asian lymphoma patients
Alexandre Chan, Xue Zhen Leng, Joen Y L Chiang, et al.
Plos One
|
February 13, 2016
Routine Primary Prophylaxis for Febrile Neutropenia with Biosimilar Granulocyte Colony-Stimulating Factor (Nivestim) or Pegfilgrastim Is Cost Effective in Non-Hodgkin Lymphoma Patients undergoing Curative-Intent R-CHOP Chemotherapy
Xiao Jun Wang, Tiffany Tang, Mohamad Farid, et al.
Acta Oncologica (Stockholm, Sweden)
|
January 14, 2011
A promising new regimen for the treatment of advanced extranodal NK/T cell lymphoma
Mohamad Farid, Ying Wei Yau, Kevin Tay, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 74) with videos related to
Sort By:
Page
of 8
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 15, 2009
Risk of hepatitis B virus reactivation in patients who are hepatitis B surface antigen negative/antibody to hepatitis B core antigen positive and the role of routine antiviral prophylaxis
Yu Xuan Koo, Daniel S W Tan, Bee Huat Tan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 15, 2012
To SMILE or not: supportive care matters
Alexandre Chan, Tiffany Tang, Terence Ng, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
June 19, 2012
Clinical pharmacy services and research for lymphoma patients at a cancer center
Alexandre Chan, Vivianne Shih, Joen Chiang, et al.
Annals of Hematology
|
August 3, 2010
Prognostic impact of bleomycin-induced pneumonitis on the outcome of Hodgkin's lymphoma
Joanne Ngeow, Iain B Tan, Ravindran Kanesvaran, et al.
Acta Oncologica (Stockholm, Sweden)
|
October 6, 2007
Capecitabine and oxaliplatin (XELOX) is safe and effective in patients with advanced gastric cancer
Richard Quek, Wan Teck Lim, Kian Fong Foo, et al.
Acta Oncologica (Stockholm, Sweden)
|
October 21, 2009
Second hematologic malignancies after ABVD: Two case reports and a retrospective study of 183 Hodgkin lymphoma patients
Carrie Leong, Joanne Ngeow, Iain Tan, et al.
World Journal of Gastroenterology
|
August 13, 2009
"Anti-HBc alone" in human immunodeficiency virus-positive and immuno-suppressed lymphoma patients
Yu Xuan Koo, Daniel S W Tan, Iain B H Tan, et al.
Asia-Pacific Journal of Clinical Oncology
|
February 22, 2011
Comparison of daily filgrastim and pegfilgrastim to prevent febrile neutropenia in Asian lymphoma patients
Alexandre Chan, Xue Zhen Leng, Joen Y L Chiang, et al.
Plos One
|
February 13, 2016
Routine Primary Prophylaxis for Febrile Neutropenia with Biosimilar Granulocyte Colony-Stimulating Factor (Nivestim) or Pegfilgrastim Is Cost Effective in Non-Hodgkin Lymphoma Patients undergoing Curative-Intent R-CHOP Chemotherapy
Xiao Jun Wang, Tiffany Tang, Mohamad Farid, et al.
Acta Oncologica (Stockholm, Sweden)
|
January 14, 2011
A promising new regimen for the treatment of advanced extranodal NK/T cell lymphoma
Mohamad Farid, Ying Wei Yau, Kevin Tay, et al.
Page
of 8